AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Snyder, R. D.
Right arrow Articles by Orrison, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Snyder, R. D.
Right arrow Articles by Orrison, W. W.

American Journal of Neuroradiology, Vol 12, Issue 6 1095-1098, Copyright © 1991 by American Society of Neuroradiology


ARTICLES

MR imaging of the spinal cord in 23 subjects with ALD-AMN complex

RD Snyder, JN King, GM Keck and WW Orrison
Department of Neurology, University of New Mexico School of Medicine, Albuquerque 87131-5281.

Twenty-three subjects from two family groups with the adrenoleukodystrophy (ALD)-adrenomyeloneuropathy (AMN) complex were examined with MR imaging at 1.5 T to determine the presence and extent of brain and spinal cord abnormalities. Nineteen individuals were identified as having ALD or AMN, or as having carrier status on the basis of pedigree analysis and/or evaluation of serum very-long-chain fatty acids. In addition to the expected intracranial white matter changes for this disorder, decreased spinal cord diameter was found in seven (30%) of the 23 subjects. In three of these cases, atrophy was limited to the thoracic spinal cord, while atrophy of both the cervical and thoracic cord was identified in four patients. Two patients who did not have MR imaging of the spine were found to have spinal cord atrophy at autopsy. The finding of decreased spinal cord diameter on MR examinations in individuals who are heterozygous for ALD-AMN, in patients with ALD or AMN, and in asymptomatic ALD-AMN patients may represent a new anatomic marker for the variable clinical presentations of this condition. In addition to cranial MR examination, MR imaging of the spine may be indicated in patients with suspected ALD or AMN, or in women with carrier status.


This article has been cited by other articles:


Home page
NeurologyHome page
S. Suda, Y. Komaba, T. Kumagai, M. Yamazaki, T. Katsumata, T. Kamiya, and Y. Katayama
Progression of the olivopontocerebellar form of adrenoleukodystrophy as shown by MRI
Neurology, January 10, 2006; 66(1): 144 - 145.
[Full Text] [PDF]


Home page
NeurologyHome page
F. Barkhof and R. C. McKinstry
Quantifying spinal cord demyelination with magnetic transfer imaging
Neurology, May 24, 2005; 64(10): 1677 - 1678.
[Full Text] [PDF]


Home page
RadiologyHome page
F. Barkhof, A. Verrips, P. Wesseling, M. S. van der Knaap, B. G. M. van Engelen, F. J. M. Gabreëls, A. Keyser, R. A. Wevers, and J. Valk
Cerebrotendinous Xanthomatosis: The Spectrum of Imaging Findings and the Correlation with Neuropathologic Findings
Radiology, December 1, 2000; 217(3): 869 - 876.
[Abstract] [Full Text]